Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 21.2.2025B.Braun Melsungen AG (BME)13744Braunol (sol der 1x5 l (kanister PE))21.2.2025O
 21.2.2025B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))21.2.2025R
 21.2.2025MEDOCHEMIE Ltd. (MOE)67563Dapril 20 mg (tbl 20x20 mg (blis.PVC/PVDC/Al))26.2.2024R
 21.2.2025MEDOCHEMIE Ltd. (MOE)53504RAMIMED 10 mg (tbl 30x10 mg (blis.Al/Al/PA/PVC))27.5.2024R
 21.2.2025IMUNA PHARM, a.s. (IMA)3463CChlorid sodný 0,9 % IMUNA ENVIBAG (sol inf 1x500 ml (vak PP-infúzny s inf.a inj.portom))21.2.2025R
 21.2.2025IMUNA PHARM, a.s. (IMA)3462CChlorid sodný 0,9 % IMUNA ENVIBAG (sol inf 1x250 ml (vak PP-infúzny s inf.a inj.portom))21.2.2025R
 21.2.2025Grifols Deutschland GmbH (GIO)4988CGamunex (sol inf 1x100 ml (liek.inj.skl.))21.2.2025R
 21.2.2025Baxalta Innovations GmbH (BXA)85677FEIBA 50 U/ml (plv iio 1x1000 U+20 ml solv.(liek.inj.skl.+prísl.))20.2.2025Z
 20.2.2025MEDOCHEMIE Ltd. (MOE)67563Dapril 20 mg (tbl 20x20 mg (blis.PVC/PVDC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)34922MEDOFLOXINE 200 mg (tbl flm 20x200 mg (blis.PVC/Al))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)65114MEDOCLAV 1,2 g (plo ijf 100x1,2 g (liek.inj.skl.))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)65111MEDOCLAV 1,2 g (plo ijf 10x1,2 g (liek.inj.skl.))17.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)53504RAMIMED 10 mg (tbl 30x10 mg (blis.Al/Al/PA/PVC))20.2.2025R
 20.2.2025MEDOCHEMIE Ltd. (MOE)67520MEDOCIPRIN 500 mg (tbl flm 10x500 mg (blis.PVC/Al))17.2.2025O
 20.2.2025MEDOCHEMIE Ltd. (MOE)40200KLERIMED 250 mg (tbl flm 14x250 mg (blis.PVC/PVDC/Al))17.2.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)